New Drugs FDA Approves Onapgo (apomorphine hydrochloride) for the Treatment of Motor Fluctuations in Adults with Advanced Parkinson’s Disease 1 year ago
Healthcare News • Pharma Industry News Cardiovascular disease medications underused globally 1 year ago
New Drugs FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Treatment of Diabetic Macular Edema 1 year ago
Healthcare News • Pharma Industry News Gene therapy may be “one shot stop” for rare bone disease 1 year ago
Integrated Pharma Magazine
